Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
Milestone Pharmaceuticals Inc. (MIST) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "- NDA submission for etripamil in patients with PSVT expected in October 2023 - Data featured during oral session at Heart Rhythm 2023 Annual Meeting support the potential of etripamil in patients with AFib-RVR"
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
06/09/2023 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits  Interac...
Docs: "Milestone Pharmaceuticals Inc."
05/31/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/15/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
05/11/2023 8-K Quarterly results
Docs: "- NDA submission for etripamil in patients with PSVT currently on track for 3Q23 - Company to host virtual KOL event focused on etripamil for the potential treatment of AFib-RVR on Monday, May 22, 2023"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/31/2023 8-K Quarterly results
03/29/2023 8-K Quarterly results
03/29/2023 10-K Annual Report for the period ended December 31, 2022
03/28/2023 8-K Quarterly results
03/27/2023 8-K Quarterly results
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
03/07/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Q3, 2023 1 2 3"
02/14/2023 SC 13G/A ORBIMED CAPITAL LLC reports a 0% stake in Milestone Pharmaceuticals, Inc.
02/14/2023 SC 13G/A RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in Milestone Pharmaceuticals Inc.
02/14/2023 SC 13G/A Venrock Healthcare Capital Partners III, L.P. reports a 6.4% stake in Milestone Pharmaceuticals Inc.
02/14/2023 SC 13G/A Boxer Capital, LLC reports a 2% stake in Milestone Pharmaceuticals Inc.
02/14/2023 SC 13G/A Ikarian Capital, LLC reports a 1.3% stake in Milestone Pharmaceuticals Inc.
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/19/2023 SC 13G GOLDMAN SACHS GROUP INC reports a 8% stake in MILESTONE PHARMACEUTICALS INC.
01/18/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/06/2022 8-K Quarterly results
11/10/2022 8-K Quarterly results
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/31/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/24/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/17/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "David Pitts Argot Partners 212-600-1902"
09/26/2022 SC 13D/A Novo Holdings A/S reports a 7% stake in Milestone Pharmaceuticals Inc.
08/10/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy